Record Details

CMFRI introduces nutraceutical from seaweed to combat fatty liver disease The New Indian Express dated 20th December 2022

CMFRI Repository

View Archive Info
 
 
Field Value
 
Relation http://eprints.cmfri.org.in/16552/
https://www.newindianexpress.com/lifestyle/health/2022/dec/20/cmfri-introduces-nutraceutical-from-seaweedto-combat-fatty-liver-disease-2530067.html
 
Title CMFRI introduces nutraceutical from seaweed to combat fatty liver disease The New Indian Express dated 20th December 2022
 
Creator CMFRI, Library
 
Subject CMFRI News Clippings
 
Description The CMFRI on Tuesday signed a Memorandum of Understanding (MoU) with Emineotech, a health products firm, for the commercial production and marketing of CadalminTM LivCure extract. CMFRI director A Gopalakrishnan signed a license agreement with Emineotech's managing director Evanjalist Pathrose for commercial production of the product.
 
Publisher The New Indian Express
 
Date 2022
 
Type Article
PeerReviewed
 
Format text
 
Language en
 
Identifier http://eprints.cmfri.org.in/16552/1/The%20New%20Indian%20Express_21-12-2022.pdf
CMFRI, Library (2022) CMFRI introduces nutraceutical from seaweed to combat fatty liver disease The New Indian Express dated 20th December 2022. The New Indian Express.